Siemens to Replace Healthineers CFO in Preparation for Listing Post author:Sam Post published:November 8, 2017 Post category:BioPharma The public listing that is expected to value the business at around $46 billion. Source: BioSpace You Might Also Like Struggling MannKind Hires Financial Advisor After Maxing Out Its Last Credit Line June 29, 2017 3 Biotechs Seeking $271M IPO in the New Year January 1, 2018 FDA Orders 6 Partial or Full Clinical Holds on Celgene's Blood Cancer Studies September 6, 2017
